From the Desk of Steve Strazza and Alfonso Depablos
The largest insider buy on today’s list comes in a Form 4 filing by Cormorant Asset Management LP.
The hedge fund reported a purchase of roughly $19.6 million in Ambrx Biopharma Inc $AMAM.
Expert technical analysis of financial markets by JC Parets
by David
From the Desk of Steve Strazza and Alfonso Depablos
The largest insider buy on today’s list comes in a Form 4 filing by Cormorant Asset Management LP.
The hedge fund reported a purchase of roughly $19.6 million in Ambrx Biopharma Inc $AMAM.
by David
From the Desk of Kimmy Sokoloff
FOMC on deck!
Now we’ll either see a quick pop up to 447.70 on $SPY or a drop down to 437 to 435.
Pre-market indices are trading higher.
by David
From the Desk of Kimmy Sokoloff
It was a slow day, and the market just drifted lower.
We’ll see what happens tomorrow after the FOMC announcement.
by David
From the Desk of Steve Strazza and Alfonso Depablos
The largest insider buy on today’s list comes in a Form 4 filing by Thurman John Rodgers, director of Enphase Energy Inc $ENPH.
Rodgers reported a purchase of $4 million in ENPH.
by David
From the Desk of Kimmy Sokoloff
The indices are stuck under their respective moving averages.
This is making it harder to find opportunities to trade.
by David
From the Desk of Kimmy Sokoloff
This is a very choppy market.
$SPY bumped up to resistance at 445 then dropped lower.
We can stay volatile this whole week.
by David
From the Desk of Steve Strazza and Alfonso Depablos
The most significant insider purchase on today’s list comes from Wayne P. Rothbaum, director of Iovance Biotherapeutics $IOVA.
Rothbaum declared a $26.5 million IOVA purchase in a Form 4 filing.
by David
From the Desk of Kimmy Sokoloff
Let’s see what this week brings, as we have the FOMC on Wednesday.
Next support down on $SPY is 440.